Archive · 13 Aug 2025
Avendus and SBI Life Invest in Aragen Life Sciences
A company called Avendus, which invests in other companies, put ₹300 crore into Aragen Life Sciences.
Another investor, SBI Life Insurance, also invested ₹150 crore.
Both bought shares from a company called Reddy Investment Trust.
Aragen Life Sciences helps other healthcare and pharmaceutical companies.
Avendus is raising money for its investment fund, and it plans to make more investments in the future.
Avendus has previously invested in La Renon Healthcare and is also partially exiting Juspay Technologies.
Avendus Future Leaders Fund (FLF) invested ₹300 crore in Aragen Life Sciences.
SBI Life Insurance also invested ₹150 crore in Aragen.
The investment was a secondary transaction from the Reddy Investment Trust.
Aragen Life Sciences is a Hyderabad-based CRDMO providing services to healthcare companies.
Avendus's FLF III fund is nearing its ₹1,500 crore target, with plans for further investments.
- Who
- Avendus FLF, SBI Life, Aragen Life Sciences, and Reddy Investment Trust are the key players.
- What
- Avendus Future Leaders Fund and SBI Life invested in Aragen Life Sciences.
- When
- The investment occurred recently, with the FLF III fund nearing its target.
- Where
- The news focuses on investments in India, with Aragen based in Hyderabad.
- Why
- Avendus invests in promising companies to help them grow and potentially profit.
- Investment Amount (Avendus)
- ₹300 crore
- Investment Amount (SBI Life)
- ₹150 crore
- Company Invested In
- Aragen Life Sciences
- Aragen's Business
- CRDMO for healthcare
- Fund Name
- Avendus Future Leaders Fund III
- Fund Target
- ₹1,500 crore